| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 12/25/2003 | US20030236230 Comprises 4-substituted piperidine ring linked to a substituted or unsubstituted hydrocarbyl ring; for controlling weight gain in a human or higher mammal |
| 12/25/2003 | US20030236222 For the prevention and/or treatment of motoneuron diseases |
| 12/25/2003 | US20030236213 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236212 Compounds useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders |
| 12/25/2003 | US20030236202 Natural products and derivatives thereof for protection against neurodegenerative diseases |
| 12/25/2003 | US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 12/25/2003 | US20030235620 Animal extracts used as lipoxygenase inhibitors, antidiabetic, antiinflammatory, antiarthritic or antidiabetic agents; molluscs |
| 12/25/2003 | US20030235609 Use of cholinesterase antagonists to treat insulin resistance |
| 12/25/2003 | US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation |
| 12/25/2003 | US20030235585 Methods of treating disorders in which TFN alpha activity is detrimental via biweekly, subcutaneous administration of human antibodies, preferably recombinant human antibodies, that specifically bind to human tumor necrosis factor alpha |
| 12/25/2003 | US20030235563 Placental derived stem cells and uses thereof |
| 12/24/2003 | WO2003106970A2 P27 prevents cellular migration |
| 12/24/2003 | WO2003106683A1 Novel screening method |
| 12/24/2003 | WO2003106628A2 Benzodiazepine inhibitors of mitochondial f>10< atp hydrolase and methods of inhibiting f>10< atp hydrolase |
| 12/24/2003 | WO2003106506A1 Low molecular weight oversulfated polysaccharide |
| 12/24/2003 | WO2003106505A1 Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
| 12/24/2003 | WO2003106504A1 Epimerized derivatives of k5 polysaccharide with a very high degree of sulfation |
| 12/24/2003 | WO2003106482A1 Peptides derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions |
| 12/24/2003 | WO2003106475A2 Process |
| 12/24/2003 | WO2003106462A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 12/24/2003 | WO2003106455A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 12/24/2003 | WO2003106450A1 Phenylaminopyrimidines and their use as rho-kinase inhibitors |
| 12/24/2003 | WO2003106444A1 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 12/24/2003 | WO2003106431A2 Novel hexahydro-pyridazine-3-carbocylic acid hydrazide or hydrazone derivatives, combinatorial libraries containing same, use thereof as medicines, pharmaceutical compositions containing same and methods for preparing same |
| 12/24/2003 | WO2003106428A1 Novel arylsulphonamide derivatives and use thereof as therapeutic agents |
| 12/24/2003 | WO2003106426A1 Compounds, compositions, and methods |
| 12/24/2003 | WO2003106425A2 Phenyl- and pyridyl-diazaheterocycles having a tnf-modulating activity |
| 12/24/2003 | WO2003106420A1 2,5-disubstituted 3-mercaptopentanoic acid |
| 12/24/2003 | WO2003106417A1 Mitotic kinesin inhibitors |
| 12/24/2003 | WO2003106416A2 Chemical process |
| 12/24/2003 | WO2003106410A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament |
| 12/24/2003 | WO2003106403A1 Carboxamides derivatives |
| 12/24/2003 | WO2003106402A1 2-naphtamide derivatives |
| 12/24/2003 | WO2003106381A2 Human adam-10 inhibitors |
| 12/24/2003 | WO2003105909A1 Medicine for prevention of and/or treatment for liver inshemiareperfusion injury and protective agent for transplant liver |
| 12/24/2003 | WO2003105908A2 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs |
| 12/24/2003 | WO2003105900A1 Regulation of secretory phospholipase a2 group iia |
| 12/24/2003 | WO2003105893A2 Probiotic therapies |
| 12/24/2003 | WO2003105886A2 Methods and uses of the integrin alpha 10 chain, for preventing progression of atherosclerosis plaque formation |
| 12/24/2003 | WO2003105872A1 Anti-spasmodic comprising xenon |
| 12/24/2003 | WO2003105871A1 Cerebral protection with a gas comprising xenon |
| 12/24/2003 | WO2003105847A1 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105844A1 Medicament combinations of sodium channel blockers and fibrinolytics for treating ischaemic conditions |
| 12/24/2003 | WO2003105842A1 Derivatives of chromen-2-one as inhibitors of vegf production in mammalian cells |
| 12/24/2003 | WO2003105838A2 Metabolite |
| 12/24/2003 | WO2003105837A1 Calcium salts of indole derived statins |
| 12/24/2003 | WO2003105834A1 Bazedoxifene treatment regimens |
| 12/24/2003 | WO2003105781A2 Ophthalmic compositions for treating ocular hypertension |
| 12/24/2003 | WO2003105779A2 Guanidine compounds as anesthetics and for treatment of nervous system disorders |
| 12/24/2003 | WO2003105775A2 Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compostions thereof |
| 12/24/2003 | WO2003105771A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 12/24/2003 | WO2003105666A2 Method of treating ischemia reperfusion injury using adenosine receptor antagonists |
| 12/24/2003 | WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
| 12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
| 12/24/2003 | WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation |
| 12/24/2003 | WO2003082807A3 Amino acids with affinity for the alpha-2-delta-protein |
| 12/24/2003 | WO2003077892A3 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3(4-pyridin-3-yl)pyrimidin-2-yl-amino)phenyl]-benzamide for treating ang ii-mediated diseases |
| 12/24/2003 | WO2003076414A3 Aryl substituted pyrimidines and the use thereof |
| 12/24/2003 | WO2003075015A3 Methods of screening apoptosis modulating compounds, compounds identified by said methods and use of said compounds as therapeutic agents |
| 12/24/2003 | WO2003072558A3 Arylsulfone derivatives |
| 12/24/2003 | WO2003068760A3 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders |
| 12/24/2003 | WO2003068725A3 Process for the preparation of 4-hetero-substituted phenylalanine derivatives |
| 12/24/2003 | WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
| 12/24/2003 | WO2003068166A3 Treatment of ophthalmic disorders using urea and urea derivatives |
| 12/24/2003 | WO2003066840A3 Pluripotent embryonic-like stem cells derived from teeth and uses thereof |
| 12/24/2003 | WO2003065044A8 Diagnostics and therapeutics for diseases associated with gpr72 |
| 12/24/2003 | WO2003064685A3 Genetic polymorphisms in the preprotachykinin gene |
| 12/24/2003 | WO2003063800A3 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 12/24/2003 | WO2003062236A8 2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d]PYRIMIDIN-7-ONES |
| 12/24/2003 | WO2003061653A9 3-(imidazolyl)-2-aminopropanoic acids for use as tafi-a inhibitors for the treatment of thrombotic diseases |
| 12/24/2003 | WO2003053361A3 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 12/24/2003 | WO2003050272A3 Bone development model |
| 12/24/2003 | WO2003047611A3 Ptp10d, tec and edtp involved in triglycerid-metabolism |
| 12/24/2003 | WO2003045981A3 Concentrating aqueous fractions of lisinopril by reverse osmosis |
| 12/24/2003 | WO2003040174A3 Substituted amino ketone compounds |
| 12/24/2003 | WO2003037362A3 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism |
| 12/24/2003 | WO2003037296A3 Methods and dosage forms for improving the bioavailability of therapeutic agents |
| 12/24/2003 | WO2003035666A3 Phosphorothioate-modified oligonucleotide as anti-restenosis agent |
| 12/24/2003 | WO2003035137A3 Method and apparatus for dispensing inhalator medicament |
| 12/24/2003 | WO2003035046A3 Salts formed of an at1-receptor antagonist and a cardiovascular agent |
| 12/24/2003 | WO2003032963A3 Method of reducing type 2 diabetes in high risk patients |
| 12/24/2003 | WO2003032900A3 Carbocyanine dyes for tandem, photodiagnostic and therapeutic applications |
| 12/24/2003 | WO2003020280B1 Compositions and use thereof in the treatment of cancer |
| 12/24/2003 | WO2003011230A3 Modified reoviral therapy |
| 12/24/2003 | WO2003007840A8 Stent vascular intervention device and method |
| 12/24/2003 | WO2003006491A3 Peptide-based compounds for targeting intergin receptors |
| 12/24/2003 | WO2002102997A3 Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 12/24/2003 | WO2002102990A8 Fibroblast growth factor and nucleic acid encoding same |
| 12/24/2003 | WO2002081703A3 Mitogenic oxygenase regulators |
| 12/24/2003 | WO2002068676A3 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING |
| 12/24/2003 | WO2002046147A3 Perturbed membrane-binding compounds |
| 12/24/2003 | WO2002018540A3 Pyridine derivatives useful as cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 12/24/2003 | WO2001085193A8 Method for promoting neovascularization using a tweak agonist and an angiogenic factor |
| 12/24/2003 | CN1462755A Method for distilling active protein liquid of scorpion |
| 12/24/2003 | CN1462750A Erigeron ester B and its preparation method as well as application in pharmacy |
| 12/24/2003 | CN1462623A Combination of Chinese herbal medicine for treating high blood pressure |
| 12/24/2003 | CN1462620A Powder of flenabane and its preparation method as well as application in making drugs |
| 12/24/2003 | CN1462616A Method of preparing medical use injection containing high oxygen |
| 12/24/2003 | CN1131870C 新的吡咯磺酰胺化合物 The new pyrrole sulfonamide compound |
| 12/24/2003 | CN1131862C 经吡咯烷基、哌啶基或高哌啶基取代的(苯并二噁烷,苯并呋喃或苯并吡喃)衍生物 After pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |